does tirzepatide pass through breast milk and breastfeeding: New research offers hope for postpartum moms Mounjaro and Breastfeeding: Latest MHRA

Clinical data shows that GLP-1 agonists lead to an average weight loss of 515% of body weight over 68 weeks, depending on dose and individual metabolism

Our microdosing subscription is designed to deliver the metabolic and anti-inflammatory benefits of Tirzepatide with a gentler, lower-dose approachideal for those seeking maintenance, improved metabolic flexibility, or a smoother introduction to GIP/GLP-1 therapy

The troubling statistics persist despite almost 50% of American adults attempting to lose weight in recent years

Similar findings were also published in early 1987 by Holst et al., who confirmed that GLP-1(7-37) is present in pig small intestine using a specific RIA (10)